PSH repair with relocation without laparotomy was associated with a significantly shorter hospital stay, possibly due to the lack of a midline abdominal wound. It may not be feasible in patients with significant intraabdominal adhesions.

No abstract

relative to those without cancer but comparable 1-, 3-, and 5-year rates, indicating risk of mortality due to cancer does not increase until well after transplantation. As expected, patients with solid organ cancers had significantly worse survival than those with cutaneous cancer, whose survival was similar to those without cancer. There were no differences in rates of rejection, suggesting a judicious reduction of immunosuppression is an appropriate component of oncologic treatment. Patients with non-metastatic disease amenable to local surgery or radiation tolerated treatment well, while patients with hematologic, lung, and colorectal cancer requiring chemotherapy developed higher rates of toxicity than patients with other cancers.

No abstract